/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.55%
Natural Gas
-4.49%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.57%
VIX
N/A
Economic Calendar
EUR/USD
-0.55%
Natural Gas
-4.49%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.57%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Euro Area Sovereign Credit: Some Ratings Under Pressure as Fiscal Challenges Mount
about 15 hours ago
CB Consumer Confidence Drops To 97.0, Missing Analyst Expectations
about 13 hours ago
Germany: Economic Outlook Stable Despite Near-term Stagnation and Fiscal Challenges
about 16 hours ago
Coca-Cola Tops Q1 Forecasts, McDonald’s Faces Middle East Issues
about 18 hours ago
MicroStrategy Bitcoin (BTC) Holdings Hits $13.6 Billion after Latest Purchase
about 21 hours ago
German Retail Sales Rise by 1.8% in March on Food Sales
about 23 hours ago
Bitcoin (BTC) News Today: Fed Jitters Impact BTC-Spot ETF Market and BTC
about 2 hours ago
XRP News Today: SEC’s Ripple Appeal Plans Casts Shadow on XRP’s Future
about 3 hours ago
USD/JPY Forecast: Eyes on FOMC Press Conference and Yen’s Fate
about 6 hours ago
Hang Seng Index, Nikkei 225, ASX 200: Futures Flash Red on Fed Jitters
about 7 hours ago
AUD to USD Forecast: Impact of US Labor Data and FOMC Decision on Currency Pair
about 6 hours ago
Bitcoin Price Forecast: Sellers Back in Charge
about 9 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
INVA
profile
Innoviva Inc
Follow
INVA
(
Nasdaq - US
)
N/A
15.12
-0.42 (-2.73%)
in
:
usd
•
As of: Apr 30, 2024 15:59
UTC -4
Open
15.45
High
15.48
Low
14.95
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Dividends
About
Innoviva Inc
CEO
Pavel Raifeld
Headquarters
1350 old bayshore highway,suite 400
burlingame, ca 94010, united states
Auditor
Deloitte & Touche LLP
Employees
112
Share Holders
63
Website
www.inva.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Innoviva Inc
Statistics
Valuation Measures
Market Capitalization
2
955.72M
Enterprise Value
1.21B
Enterprise Value/EBITDA
(ttm)
7.97
Price to Earnings Ratio
(ttm)
6.81
Price to Book
(mrq)
1.43
Price to Sales
(ttm)
3.11
Price to Cash
(ytd)
4.36
Profitability
Gross Margin
(ttm)
86.23%
Operating Margin
(ttm)
59.15%
Profit Margin
(ttm)
60.22%
Return on Equity
(ttm)
30.37%
Return on Invested Capital
(ttm)
16.73%
Return on Assets
(ttm)
15.70%
Income Statement
Revenue
(ttm)
310.46M
Revenue Per Share
(ttm)
4.91
Gross Profit
(ttm)
267.82M
EBITDA
(ttm)
3
151.66M
Net Income Avi to Common
(ttm)
179.72M
Diluted EPS
(ttm)
2.18
Share Statistics
Beta (5Y Monthly)
0.57
52-Week Change
29.30%
S&P500 52-Week Change
24.15%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
63.23M
Dividend Yield
0.00%
Float
4
62.34M
%
Held by Insiders
1.40%
%
Held by Institutions
99.12%
Balance Sheet
Total Cash
(mrq)
193.51M
Total Cash Per Share
(mrq)
3.06
Total Debt
(mrq)
446.23M
Total Debt/Equity
(mrq)
66.11%
Current Ratio
(mrq)
9.03%
Quick Ratio
(mrq)
7.96%
Book Value Per Share
(mrq)
10.66
Cash Flow
Operating Cash Flow Per Share
(ytd)
1.62
Free Cash Flow
(ytd)
140.65M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker